Start here if you're new
what it is
Birkenstock sells premium sandals and shoes built around its signature footbed, with production centered in Germany.
how it gets paid
Last year Birkenstock made $2.3B in revenue. sandals was the main engine at $1.48B, or 74% of sales.
what just happened
Fiscal Q1 2026 revenue reached €402M, and EPS beat expectations even as gross margin slid.
At a glance
B+ balance sheet — decent shape, but not bulletproof
20.1x trailing p/e — priced about right
9.5% return on capital — nothing to write home about
$2.40 fy2026 eps est
$4B fy2028 rev est
xvary composite: 55/100 — below average
What they do
Birkenstock sells premium sandals and shoes built around its signature footbed, with production centered in Germany.
Birkenstock wins because the product is simple, recognizable, and hard to fake at scale. The company makes all of its footbeds in Germany and sells in around 100 countries, which gives you brand consistency and supply control. Vertically integrated production (it makes key parts itself → less supplier dependence → more control) matters more when demand is outrunning capacity.
How they make money
$2.3B
annual revenue
sandals
$1.48B
+15.0%
closed-toe footwear
$0.36B
+18.0%
professional and kids
$0.10B
+11.0%
accessories and other
$0.06B
+11.0%
The products that matter
manufactures core footwear component
Footbeds
made in Germany
Birkenstock says it makes all of its footbeds in Germany. That matters because the comfort story helps support 32.0% operating margin on a $2.3B revenue base.
brand identity
premium open-toe footwear
Core sandals
center of gravity
This is the part of the brand most consumers know. The snapshot does not break out segment sales, which means you should treat the full $2.3B business as one concentrated brand bet.
core demand
footwear and accessories extension
Accessories and adjacent lines
brand extension
Accessories matter less for size than for brand reach. With 9.5% return on capital, Birkenstock still needs these extensions to earn more, not just sell more.
execution watch
Key numbers
20.1x
trailing p/e
You are paying 20.1 times past earnings for a brand still dealing with production limits, not a fully scaled machine.
32.0%
operating margin
Operating margin (profit after running the business → core earning power → room to absorb shocks) at 32.0% is unusually high for footwear.
$1.3B
long-term debt
Debt is real, but it is only 15% of capital, which keeps the balance sheet from becoming the story.
$65
18-month target
That target is 56% above $41.76, so the upside case is obvious. The question is whether factories can catch up.
Financial health
B+
strength
- balance sheet grade B+ — solid but not elite
- risk rank 3 — safer than 50% of stocks
- long-term debt $1.3B (15% of capital)
- net profit margin 17.5% — keeps 18 cents of every dollar in revenue
- return on equity 12% — $0.12 profit for every $1 investors have put in
B+ — functional but not a standout on the balance sheet.
Total return vs. market
Return history isn't available for BIRK right now.
source: institutional data · return history unavailable
What just happened
beat estimates
Fiscal Q1 2026 revenue reached €402M, and EPS beat expectations even as gross margin slid.
Revenue rose 11% reported and 18% in constant currency. EPS came in at $0.27, about 3.85% above expectations, but gross margin fell 460 basis points to 55.7%, which says growth is arriving with some friction.
€402M
revenue
$0.27
eps
55.7%
gross margin
the number that mattered
18% constant-currency growth mattered most because it strips out FX noise and shows demand is still strong even while production looks constrained.
-
despite a double-digit revenue beat in the september quarter, birkenstock shares plummeted as investors reacted to a fiscal 2026 outlook marked by slowing top-line growth and margin erosion.headwinds include a projected 100-basis-point hit from incremental u.s. tariffs and significant foreign exchange volatility.
-
management’s guidance for 13% to 15% constantcurrency growth is a sharp deceleration from the 20% seen in the fourth quarter.
-
this suggests the brand is hitting a manufacturing ceiling.this ‘‘physics over demand’’ bottleneck stems from the shift toward complex closed-toe products such as the boston clog, which require twice the production time of traditional sandals and erode ebitda margins.
-
to right the ship, birkenstock is pivoting to a capacity-expansion model.immediate output gains are expected from a portugal stitchery, while a new 18 million european facility is slated for 2027 to unlock additional footbed assembly. to combat tariff-induced margin dilution, the company is aggressively reallocating inventory toward asia-pacific, its highest average selling price region. while wall street remains skeptical of the shift toward wholesale, management defends the move as a critical customer-acquisition engine, promising a stronger, marginaccretive second half of fiscal 2026 as foreign exchange pressures subside. the long-term investment thesis remains anchored in birkenstock’s unique position as a vertically integrated, iconic brand with high scarcity value.
-
unlike competitors, the company manufactures over 95% of its products in-house, ensuring quality control and reduced supply chain risk.while the market is fixated on near-term bottlenecks, the company is poised for medium-term expansion driven by its core arizona and boston styles, and geographic growth in asia. with revenues now surpassing two billion euros and high full-price sellthrough rates, birk’s industry-leading profitability remains intact despite a challenging global retail environment. with resilient demand and solid growth prospects, long-term price appreciation potential is above average.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
The #1 risk here is single-brand concentration. If consumer taste shifts against Birkenstock, the damage reaches essentially the whole $2.3B revenue base at once.
high
single-brand concentration
Birkenstock is the story. That's powerful when the brand is hot and painful when fashion rotates away. This is not a multi-brand hedge.
exposes nearly all $2.3B in revenue to one brand identity
high
customer concentration
54% customer concentration means a small group of partners matters a lot. For a premium brand, that is more channel dependence than you want.
54% of revenue tied to top customers
med
foreign currency exposure
The filing flags foreign currency risk tied to intercompany receivables for inventory. That means reported results can get pushed around even if unit demand is stable.
reported revenue and profit can swing with fx moves
med
quality multiple without elite returns
20.1x trailing earnings is fine if the business keeps looking premium. At 9.5% return on capital, that case still needs work.
multiple risk rises if returns stay near 9.5%
The combined risk picture is concentrated: one brand, meaningful customer exposure, and a premium multiple resting on good margins rather than elite capital returns.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
margin discipline
17.5% net margin and 32.0% operating margin are the whole quality case. If those slip, the premium multiple gets harder to defend fast.
risk
customer concentration
54% of revenue tied to top customers means distribution relationships matter almost as much as brand heat.
calendar
next earnings report
This snapshot does not show the next reporting date. Annoying, yes. More important: watch whether margins and estimated EPS still hold.
trend
institutional flow
Net buying for 3 quarters is a positive signal, but 141 buyers versus 134 sellers in 3Q2025 says conviction is modest.
Analyst rankings
street upside
+56%
Midpoint target is $65 versus $41.76 today. In human-speak, analysts think the stock has more room than the market is giving it.
target range
$55–$85
Even the low end sits above the current price. That's support for the story, not proof the story is right.
xvary composite
55 / 100
Our score lands below average because strong margins meet only middling returns on capital and a business profile with real concentration risk.
source: institutional data
Institutional activity
institutions have been net buying for 3 consecutive quarters — 141 buyers vs. 134 sellers in 3q2025. total institutional holdings: 0.2B shares. net buying for 3 quarters.
source: institutional data
Price targets
3-5 year target range
$35
$94
$42
current price
$65
target midpoint · +56% from current · 3-5yr high: $85 (+105% · 19% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive